Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.63%
#4 aPriori aPriori +192.70%
#5 Bedrock Bedrock +77.76%
#6 Cysic Cysic +52.73%
#7 Prom Prom +46.24%
#8 Playnance Playnance +34.82%
#9 Bitway Bitway +27.08%
#10 COTI COTI +24.13%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.

Claritas Pharmaceuticals, Inc.

CLAZF
Classement en actions #42176
Operating as a clinical-stage specialty pharmaceutical entity, Claritas... Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$3.66K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Claritas Pharmaceuticals, Inc. (CLAZF)

Catégorie

Healthcare
Ratio P/B pour Claritas Pharmaceuticals, Inc. (CLAZF)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Claritas Pharmaceuticals, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Claritas Pharmaceuticals, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR